Procarbazine in Treating Patients With Recurrent Brain Tumor
NCT00004004
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Brain and Central Nervous System Tumors
Interventions
DRUG:
procarbazine hydrochloride
Sponsor
New Approaches to Brain Tumor Therapy Consortium
Collaborators
[object Object]